The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 360:1788 April 23, 2009 Number 17
NextNext

Vitiligo

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Taïeb, A.
-PubMed Citation
To the Editor: In their Clinical Practice article on vitiligo, Taïeb and Picardo (Jan. 8 issue)1 do not include data to provide support for the use of some combination therapies. Recent evidence suggests that the combination of erbium:yttrium–aluminum–garnet (YAG) laser skin ablation with fluorouracil application before narrow-band ultraviolet B (UVB) phototherapy confers a benefit as compared with phototherapy alone.2 In addition, the authors state that it is unclear whether topical corticosteroid treatment with UVB radiation is superior to UVB radiation alone. However, we have reported a significant benefit of the combination of excimer laser UVB phototherapy and topical hydrocortisone 17-butyrate . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.